다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Senti Biosciences Inc (SNTI)
Senti Biosciences Inc (SNTI) 뉴스

SNTI

Senti Biosciences (SNTI)

Senti Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SNTI

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/30	05:14	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/30	05:09	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/30	05:07	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/18	06:19	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/18	06:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/13	21:15	GlobeNewswire Inc.	Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/10	05:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNTI	Senti Biosciences Inc
2024/05/10	05:05	GlobeNewswire Inc.	Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights	NASDAQ:SNTI	Senti Biosciences Inc
2024/04/30	21:05	GlobeNewswire Inc.	Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)	NASDAQ:SNTI	Senti Biosciences Inc
2024/03/22	05:05	GlobeNewswire Inc.	Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights	NASDAQ:SNTI	Senti Biosciences Inc
2024/01/06	06:05	GlobeNewswire Inc.	Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program	NASDAQ:SNTI	Senti Biosciences Inc
2023/12/22	20:30	GlobeNewswire Inc.	Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia	NASDAQ:SNTI	Senti Biosciences Inc
2023/11/14	06:15	GlobeNewswire Inc.	Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates	NASDAQ:SNTI	Senti Biosciences Inc
2023/11/07	06:05	GlobeNewswire Inc.	Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China	NASDAQ:SNTI	Senti Biosciences Inc
2023/10/31	22:06	GlobeNewswire Inc.	Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/09/27	22:05	GlobeNewswire Inc.	Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/09/27	05:05	GlobeNewswire Inc.	Senti Bio to Participate in Upcoming Conferences	NASDAQ:SNTI	Senti Biosciences Inc
2023/09/05	21:30	GlobeNewswire Inc.	Senti Bio to Participate in Upcoming Investor Conferences	NASDAQ:SNTI	Senti Biosciences Inc
2023/08/11	21:35	GlobeNewswire Inc.	Senti Bio Announces Second Quarter 2023 Results and Pipeline Updates	NASDAQ:SNTI	Senti Biosciences Inc
2023/08/10	21:35	GlobeNewswire Inc.	Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon Partners	NASDAQ:SNTI	Senti Biosciences Inc
2023/05/20	21:05	GlobeNewswire Inc.	Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/05/10	05:05	GlobeNewswire Inc.	Senti Bio Announces First Quarter 2023 Results and Pipeline Updates	NASDAQ:SNTI	Senti Biosciences Inc
2023/05/03	05:45	GlobeNewswire Inc.	Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/04/17	21:45	GlobeNewswire Inc.	Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/04/14	22:00	GlobeNewswire Inc.	Senti Bio to Participate in Upcoming Investor Conferences	NASDAQ:SNTI	Senti Biosciences Inc
2023/03/23	06:09	GlobeNewswire Inc.	Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent Highlights	NASDAQ:SNTI	Senti Biosciences Inc
2023/03/15	05:35	GlobeNewswire Inc.	Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR Meeting	NASDAQ:SNTI	Senti Biosciences Inc
2023/02/04	06:05	GlobeNewswire Inc.	Senti Biosciences Announces New Employment Inducement Grants	NASDAQ:SNTI	Senti Biosciences Inc
2023/02/02	06:05	GlobeNewswire Inc.	Senti Bio to Present at the SVB Securities Global Biopharma Conference	NASDAQ:SNTI	Senti Biosciences Inc
2023/01/27	22:00	GlobeNewswire Inc.	Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway Guidance	NASDAQ:SNTI	Senti Biosciences Inc

검색 관련기사 보기:NASDAQ:SNTI

1 2 3 다음 >>

Financial Select Sector

American Express

Bank of America

Deutsche Telekom (QX)

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관